Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer

被引：0
|
作者：
Alessandro Di Federico
Ilaria Ricciotti
Valentina Favorito
Sandra Vietti Michelina
Pietro Scaparone
Giulio Metro
Andrea De Giglio
Federica Pecci
Giuseppe Lamberti
Chiara Ambrogio
Biagio Ricciuti
机构：
[1] Dana-Farber Cancer Institute,Lowe Center for Thoracic Oncology
[2] University of Bologna,Department of Medical and Surgical Sciences
[3] University of Torino,Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology, Center
[4] Santa Maria Della Misericordia Hospital,Medical Oncology
来源：
Current Oncology Reports | 2023年 / 25卷
关键词：
Non-small cell lung cancer; KRAS inhibitors; KRAS; Adagrasib; Sotorasib; Resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1017 / 1029
页数：12
相关论文
共 50 条
  • [11] Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer
    Cui, Wanyuan
    Franchini, Fanny
    Alexander, Marliese
    Officer, Ann
    Wong, Hui-Li
    IJzerman, Maarten
    Desai, Jayesh
    Solomon, Benjamin J.
    LUNG CANCER, 2020, 146 : 310 - 317
  • [12] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Lee, Arnold
    TARGETED ONCOLOGY, 2022, 17 (06) : 727 - 733
  • [13] Aurora kinase A inhibition overcome adaptive resistance to KRAS G12C inhibitor by G1-checkpoint induced apoptosis in KRAS non-small cell lung cancer
    Li, Chendi
    Chang, Jeremy
    Syed, Mohammed U.
    Nimbalkar, Anahita
    Shen, Yi
    Altschuler, Steve
    Wu, Lani
    Gong, Xueqian
    Hata, Aaron
    CANCER RESEARCH, 2023, 83 (07)
  • [14] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2022, 17 : 727 - 733
  • [15] Correction to: Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2023, 18 : 177 - 177
  • [16] KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
    Park, Sehhoon
    Kim, Ji-Yeon
    Lee, Se-Hoon
    Suh, Beomseok
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 514 - 522
  • [17] GTPase KRAS (G12C mutant) inhibitor Treatment of non-small cell lung cancer Treatment of colorectal cancer
    Shao, Shi-yun
    Rong, Wen-qing
    Talukder, Salehikram
    Jia, Ru
    Chen, Zhe-Sheng
    DRUGS OF THE FUTURE, 2022, 47 (11) : 783 - 795
  • [18] Chromatin modification driving sub-clonal resistance to KRAS G12C combination therapies in KRAS mutant non-small cell lung cancer
    Li, Chendi
    Qin, Qian
    Syed, Mohammed Usman
    Nimbalkar, Anahita
    Karakyriakou, Barbara
    Clark, Sarah E.
    Saiki, Anne Y.
    Hughes, Paul E.
    Ott, Chris
    Pinello, Luca
    Hata, Aaron N.
    CANCER RESEARCH, 2023, 83 (07)
  • [19] Activity and resistance to KRASG12C G12C inhibitors in non-small cell lung cancer and colorectal cancer
    Ye, Wei
    Lu, Xin
    Qiao, Yue
    Ou, Wen-Bin
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [20] Tissue factor overexpression promotes resistance to KRAS-G12C inhibition in non-small cell lung cancer
    Zhang, Yu
    Liu, Liang
    Pei, Jinpeng
    Ren, Zhiqiang
    Deng, Yan
    Yu, Ker
    ONCOGENE, 2024, 43 (09) : 668 - 681
12345